3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
CNS
1
Conditions
Brain Neoplasms
12
Central Nervous System Neoplasms
11
Glioblastoma
10
Gliosarcoma
8
Glioma
7
Astrocytoma
4
Oligodendroglioma
3
Neuroblastoma
3
Melanoma
3
Medulloblastoma
3
Sarcoma
2
Recurrence
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive
2
Neoplasms
2
Ependymoma
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pinealoma
1
Interventions
Filgrastim
9
X-Rays
7
Phantoms, Imaging
7
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Granulocyte Colony-Stimulating Factor
6
Temozolomide
5
Nuclear Medicine Department, Hospital
5
Melphalan
5
Cyclophosphamide
5
Busulfan
5
Stem Cell Transplantation
4
Carboplatin
4
Biopsy
4
Topotecan
3
Thiotepa
3
Radiotherapy
3
Peripheral Blood Stem Cell Transplantation
3
Itraconazole
3
Ifosfamide
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
sargramostim
2
palbociclib
2
olaparib
2
liposomal amphotericin B
2
larotrectinib
2
ixabepilone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wilms Tumor
×
Thalidomide
×
CNS
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled